Alzamend Neuro (ALZN) Depreciation & Amortization (CF) (2022 - 2026)
Alzamend Neuro's Depreciation & Amortization (CF) came in at $27,685 for fiscal Q1 2027 (quarter ended Jul 31, 2026), unchanged from $27,685 a year earlier and unchanged from the prior quarter.
Alzamend Neuro (ALZN) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, Alzamend Neuro reported Depreciation & Amortization (CF) of $110,740, up 68.5% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $110,740, up 118.2% from FY2025.
- Depreciation & Amortization (CF) carries a four-year compound annual growth rate of 136.3% (FY2022 to FY2026).
- Going back by fiscal year, Depreciation & Amortization (CF) was $50,740 in FY2025 (unchanged), $50,740 in FY2024 (+120.0%), $23,066 in FY2023 (+549.9%) and $3,549 in FY2022.
- Year-over-year, Depreciation & Amortization (CF) increased in four of the last eight quarters, with growth averaging 59.1%.
- Across the past five years, year-over-year growth in Depreciation & Amortization (CF) ran from 0.0% in fiscal Q1 2025 to 138.3% in fiscal Q4 2024.
- Business Quant data shows ALZN's Depreciation & Amortization (CF) at $27,685 (Q4 2026), $27,685 (Q3 2026) and $27,685 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Alzamend Neuro | 6.37 Mn | 6.37 Mn | - | 27,685.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 27,685.00 |
| Apr 30, 2026 | 27,685.00 |
| Jan 31, 2026 | 27,685.00 |
| Oct 31, 2025 | 27,685.00 |
| Jul 31, 2025 | 27,685.00 |
| Apr 30, 2025 | 12,685.00 |
| Jan 31, 2025 | 12,685.00 |
| Oct 31, 2024 | 12,685.00 |
| Jul 31, 2024 | 12,685.00 |
| Apr 30, 2024 | 12,685.00 |
| Jan 31, 2024 | 12,685.00 |
| Oct 31, 2023 | 12,685.00 |
| Jul 31, 2023 | 12,685.00 |
| Apr 30, 2023 | 5,323.00 |
| Jan 31, 2023 | 5,323.00 |
| Oct 31, 2022 | 5,323.00 |
| Jul 31, 2022 | 7,097.00 |
Alzamend Neuro Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();